Format

Send to

Choose Destination
Pediatr Blood Cancer. 2013 May;60(5):771-5. doi: 10.1002/pbc.24454. Epub 2013 Jan 9.

Causes, outcome and prevention of abandonment in retinoblastoma in India.

Author information

1
Division of Paediatric Haematology-Oncology, Department of Paediatrics, King George's Medical University Lucknow, Uttar Pradesh, India. archanakumar53@yahoo.co.in

Abstract

BACKGROUND:

The high-cure rates of 90% in retinoblastoma are not replicated in developing countries due to late presentation and poor compliance to treatment. The present study takes a closer look at causes of abandonment of therapy and effectiveness of counselling in reducing abandonment.

PROCEDURE:

A retrospective study of children with retinoblastoma registered at our centre from March 2008 through August 2011.

RESULTS:

Fifty (49.50%) of 101 children registered for treatment abandoned therapy. Abandonment rates were significantly higher in rural as compared to urban children (P = 0.02). There was no significant difference in rate of abandonment between stages or laterality of disease and other socio-demographic factors. Telephone calls were more effective than letters in tracing patients (31.2% vs. 2.4%). Major reasons cited behind abandonment were financial problems (30%) and unwillingness to enucleate (20%). Of the 12 children who returned and were retreated 6 (50%) died of progressive disease. Nineteen (73%) of those who did not return died at home. Abandonment rates steadily declined from 71.42% in 2008 to 16.66% in 2011 (P = 0.01) due to effective pre-abandonment counselling by a support team under the National Retinoblastoma Registry of India from 2009.

CONCLUSIONS:

Abandonment rates for children with retinoblastoma continue to be unacceptably high. Rural background, financial constraints and hesitancy to enucleate were important causes behind abandonment. Outcome of patients who abandoned treatment was uniformly dismal. Inclusion of support team and intensified initial counselling helped in improving compliance.

PMID:
23303533
DOI:
10.1002/pbc.24454
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center